Talk:Evidence based assessment/Generalized anxiety disorder (assessment portfolio)
General comments 03/8/18
Last few studies are much older (late 90s), are they as useful?
Could add ICD criteria Could add DSM-IV to 5 changes Maybe collapse less important/less ideal measures (eg: based on DSM-IV, not free measures) Maybe have references that indicate certain measures have good reliability and validity; currently only based on book Maybe link to explanations for reliability/validity information (HAVE A SEPARATE PAGE FOR ALL THE TERMS) If measures has PDF, link to home page of that measure instead of direct PDF; allows for linkage to multiple versions "Best recommended for" column should be deleted if it's not going to be fleshed out
Is this the right medication that should be listed? Specific dosage seems a lot and not applicable
Process and outcome measures
Hard to explain table, could use some explaining
Drop suggestions and next to-dos in their respective sections. For each section, please add four tildes (~~~~). This is to add a timestamp and your username next to your suggestion.
Dimensions of Sexual Orientation and the Prevalence of Mood and Anxiety Disorders in the United States: Found an article that provides info about prevalence of anxiety disorder for LGBTQs (Bostwick et al. , 2010)--Kateforay (discuss • contribs) 23:39, 1 March 2018 (UTC)
A Cross-Ethnic Comparison of Lifetime Prevalence Rates of Anxiety Disorders: Found a paper that uses national survey data to determine the lifetime prevalence of anxiety disorder of White Americans, African Americans, Asian Americans, and Hispanic Americans (Asnaani et al., 2010)--Kateforay (discuss • contribs) 23:25, 1 March 2018 (UTC)
Hard to find SCID diagnosis measures in PDF form that are consistent
Consider adding the GAD-7 Scale (https://www.integration.samhsa.gov/clinical-practice/GAD708.19.08Cartwright.pdf) Emileekruchten (discuss • contribs) 22:32, 1 March 2018 (UTC)
Spanish Version for GAD-7 Scale as well (http://www.coloradohealthpartnerships.com/provider/integrated/GAD7-Spanish.pdf) Emileekruchten (discuss • contribs) 22:45, 1 March 2018 (UTC)
Found screening scales called the K10 and K6 scales (aka Kessler Psychological Stress Scale) used by NHIS. It is available in a variety of different languages https://www.hcp.med.harvard.edu/ncs/k6_scales.php --Kateforay (discuss • contribs) 23:12, 1 March 2018 (UTC)
Consider adding exposure therapy (https://www.sciencedirect.com/science/article/pii/S088761850700103X) and modeling therapy to "Behavioral Interventions" Emileekruchten (discuss • contribs) 23:36, 1 March 2018 (UTC)
Found a new type of treatment for GAD: Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. https://www.ncbi.nlm.nih.gov/pubmed/7649463 There was a significant reduction in symptoms and long-term effects --Kateforay (discuss • contribs) 23:25, 1 March 2018 (UTC)
Process and outcome measures
Removed: Recommended diagnostic instruments Anxiety Disorders Interview Schedule for Children/Parents (ADIS-C/P) Almost all available publications so far were evaluating the use of ADIS-C/P under the DSM-IV framework. Within those studies, ADIS-C/P demonstrated decent convergent and discriminant validity with other self-report anxiety measures such as the Multidimensional Anxiety Scale for Children (MASC; March et al., 1997; Wood et al., 2002). However, it is worth noting that MASC predicts GAD poorly (AUC ranges from .55 - .65; Van Gastel et al., 2008).
In addition to its concurrent validity, ADIS-C/P also demonstrated high interrater reliability between parents and children for general anxiety disorder (kappa = .8; Lyneham et al., 2007).